Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_03054 |
| Species: | Mus musculus |
| Position : | chr3:60330708-60331205 |
| Year: | 2020 |
| Title: | Inhibition of cyclooxygenase-1 by nonsteroidal anti-inflammatory drugs demethylates MeR2 enhancer and promotes Mbnl1 transcription in myogenic cells |
| Genome Build: | mm10 |
| Enhancer Type: | Enhancer |
| Condition: | Normal |
| Disease Name: | -- |
| PMID: | 32054946 |
| MONDO: | |
| Tissue: | Skeletal muscle |
| Tissue Ontology ID: | UBERON:0001134 |
| Cell Source: | C2C12 myoblasts |
| CVCL ID: | CVCL_0188 |
| Cell Type: | myoblast |
| Cell Ontology ID: | CL:0000187 |
| Experiment Type: | Enhancer activity assay, Functional perturbation assay |
| High Throughput Method: | |
| Low Throughput Method: | Luciferase Reporter Assay, CRISPR Knockout, Bisulfite Sequencing PCR, qRT-PCR, Western blot |
| Target gene : | Mbnl1 |
| TF name : |
| Regulatory State : | Silenced |
| GeneName | Pathway Name | Source | Gene Number |
|---|